All News #Library
Biotech
Virometix Reports Positive Phase 1 Data For V-212 Trail, Vaccine
08 Jan 2026 //
PHARMIWEB
Virometix Raises $15M for Next-Generation Synthetic V-212 Vaccine
13 Nov 2025 //
BUSINESSWIRE
Virometix Completes Enrollment In V-212 Phase I Trial
29 Sep 2025 //
BUSINESSWIRE
Virometix Appoints Christina as Chair And Board Member
08 Oct 2024 //
BUSINESSWIRE

Market Place
Sourcing Support